Shaw, M. & Mandell, B. F.Perioperative management of selected problems in patients with rheumatic diseases. Rheum. Dis. Clin. North Am. 1999; 25: 623–638.CrossRefGoogle ScholarPubMed

Schafer, A. I.Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J. Clin. Pharmacol. 1995; 35: 209–219.CrossRefGoogle ScholarPubMed

Lind, S. E.The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547–2551.Google Scholar

Gewirtz, A. S., Miller, M. L., & Keys, T. F.The clinical usefulness of the preoperative bleeding time. Arch. Pathol. Lab. Med. 1996; 120: 353–356.Google ScholarPubMed

Connelly, C. S. & Panush, R. S.Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch. Intern. Med. 1991; 151: 1963–1966.CrossRefGoogle ScholarPubMed

Bashein, G., Nessly, M. L., Rice, A. L.et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. Arch. Intern. Med. 1991; 151: 89–93.CrossRefGoogle ScholarPubMed

An, H. S., Mikhail, W. E., Jackson, W. T.et al. Effects of hypotensive anesthesia, nonsteroidal antiinflammatory drugs, and polymethylmethacrylate on bleeding in total hip arthroplasty patients. J. Arthroplasty 1991; 6: 245–250.CrossRefGoogle ScholarPubMed

Robinson, C. M., Christie, J., & Malcolm-Smith, N.Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J. Arthroplasty 1993; 8: 607–610.CrossRefGoogle ScholarPubMed

Hench, P. S., Kendall, E. C., Slocumb, C. H.et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of the pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Proc. Staff. Meet. Mayo Clin. 1949; 24: 181.Google ScholarPubMed

Coursin, D. B. & Wood, K. E.Corticosteroid supplementation for adrenal insufficiency. J. Am. Med. Assoc. 2002; 287: 236–240.CrossRefGoogle ScholarPubMed

Esteban, N. V., Loughlin, T., Yergey, A.et al. Daily cortisol production in man determined by stable isotope dilution/mass spectrometry. J. Clin. Endocrinol. Metab. 1991; 72: 39–45.CrossRefGoogle ScholarPubMed

Krasner, A. S.Glucocorticoid-induced adrenal insufficiency. J. Am. Med. Assoc. 1999; 282: 671–676.CrossRefGoogle ScholarPubMed

Lamberts, S. W. J., Bruining, H. A., & DeJong, F. H.Corticosteroid therapy in severe illness. N. Engl. J. Med. 1997; 337: 1285–1292.CrossRefGoogle ScholarPubMed

Munck, A., Guyre, P. M., & Holbrook, N. J.Physiological fractures of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 1984; 5: 25–44.CrossRefGoogle Scholar

Fraser, C. G., Preuss, F. S., & Bigford, W. D.Adrenal atrophy and irreversible shock associated with cortisone therapy. J. Am. Med. Assoc. 1952; 149: 1542–1543.CrossRefGoogle ScholarPubMed

Lewis, L., Robinson, R. F., Yee, J.et al. Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone infusion. Ann. Intern. Med. 1953; 39: 116–125.Google Scholar

Graber, A. L., Ney, R. L., Nicholson, W. E.et al. Natural history of pituitary–adrenal recovery following long-term suppression with corticosteroids. J. Clin. Endocrinol. Metab. 1965; 25: 11–16.CrossRefGoogle ScholarPubMed

Axelrod, L.Corticosteroid therapy. Medicine 1976; 55: 39–65.CrossRefGoogle Scholar

Treadwell, B. L. J., Savage, O., Sever, E. D.et al. Pituitary–adrenal function during corticosteroid therapy. Lancet 1963; 1: 355–358.CrossRefGoogle ScholarPubMed

Jasani, M. K., Boyle, J. A., Greig, W. R.et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Quast. J. Med. 1967; 143: 261–276.Google Scholar

Meakin, J. W., Tantongco, M. S., Crabbe, J.et al. Pituitary–adrenal function following long-term steroid therapy. Am. J. Med. 1960; 29: 459–464.CrossRefGoogle Scholar

Streck, W. F. & Lockwood, D. H.Pituitary adrenal recovery following short-term suppression with corticosteroids. Am. J. Med. 1979; 66: 910–914.CrossRefGoogle ScholarPubMed

LaRochelle, G. E., LaRochelle, A. G., Ratner, R. E.et al. Recovery of the hypothalamic–pituitary–adrenal axis in patients with rheumatic diseases receiving low-dose prednisone. Am. J. Med. 1993; 326: 258–264.CrossRefGoogle Scholar

Salem, M., Tainsh, R. E., Bromberg, J.et al. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann. Surg. 1994; 219: 416–425.CrossRefGoogle ScholarPubMed

Streck, W. F. & Lockwood, D. W.Pituitary adrenal recovery following short-term suppression with corticosteroids. Am. J. Med. 1979; 66: 910–914.CrossRefGoogle ScholarPubMed

Kremer, J. M.Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Ann. Intern. Med. 2001; 134: 695–706.CrossRefGoogle ScholarPubMed

Bridges, S. L. Jr. & Moreland, L. W.Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery. Rheum. Dis. Clin. North Am. 1997; 23: 981–993.CrossRefGoogle ScholarPubMed

Bridges, S. L. Jr., Lopez-Mendez, A., Han, K. H.et al. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J. Rheumatol. 1991; 18: 984.Google ScholarPubMed

Perhala, R. S., Wilke, W. S., Clough, J. D.et al. Local infectious complications following knee joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum. 1991; 34: 146.CrossRefGoogle Scholar

Kasdan, M. L. & June, L.Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 1993; 16: 1233.Google ScholarPubMed

Sany, J., Anaya, J. M., Canovas, F.et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J. Rheumatol. 1993; 20: 1129.Google ScholarPubMed

Alarcon, G. S., Moreland, L. W., Jaffe, K.et al. The use of methotrexate perioperatively in patients with rheumatoid arthritis undergoing major joint replacement surgery: Will we ever have a consensus about its use? J. Clin. Rheumatol. 1996; 2: 86.CrossRefGoogle Scholar

Grennan, D. M., Gray, J., Loudon, J.et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Ann. Rheum. Dis. 2001; 60: 214–217.CrossRefGoogle Scholar

Howland, W. L.Methotrexate-associated bone marrow suppression following surgery. Arthritis Rheum. 1988; 31: 1586–1587.CrossRefGoogle ScholarPubMed

Buchbinder, R., Hall, S., Harkness, A.et al. Severe bone marrow failure due to low dose methotrexate. J. Rheumatol. 1988; 15: 1586–1588.Google Scholar

Gutierrez-Urena, S., Molina, J. F., Garcia, C. O.et al. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 1996; 39: 272–276.CrossRefGoogle ScholarPubMed

Wluka, A. E., Buchbinder, R., Mylvaganam, A.et al. Long-term community based methotrexate use in rheumatoid arthritis: 12 year follow up of 460 patients. J. Rheumatol. 2000; 27: 1864–1871.Google Scholar

Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Osteoporos Int. 1991; 1: 114–117.CrossRef

Hawker, G. A.The epidemiology of osteoporosis. J. Rheumatol. 1996; 23 Suppl. 45: 2–5.Google Scholar

Smith, M. D., Ross, W., & Ahern, M. J.Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J. Rheumatol. 2001; 28: 2504–2508.Google ScholarPubMed

Ross, P. D., Davis, J. W., Epstein, R. S.et al. Pre-existing fractures and bone mass predict fracture incidence in women. N. Engl. J. Med. 1995; 332: 767–773.Google Scholar

Owen, R. A., Melton, L. J. III, Ilstrup, D. M.et al. Colles' fracture and subsequent hip fracture risk. Clin. Orthop. Relat. Res. 1982; 171: 37–43.Google Scholar

Mallmin, H., Ljunghall, S., Persson, I.et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif. Tissue Int. 1993; 52: 269–272.CrossRefGoogle ScholarPubMed

Khan, S. A., deGeus, C., Holroyd, B.et al. Osteoporosis follow-up after wrist fractures following minor trauma. Arch. Intern. Med. 2001; 161: 1309–1312.CrossRefGoogle ScholarPubMed

Freedman, K. B., Kaplan, F. S., Bilder, W. B.et al. Treatment of osteoporosis: are physicians missing an opportunity? J. Bone Joint Surg. 2000; 82-A: 1063–1070.CrossRefGoogle ScholarPubMed

Broy, S. B., Bohren, A., Harrington, T.et al. Are physicians treating osteoporosis after hip fracture? Arthritis Rheum. 2000; 43: S203.Google Scholar

Wortmann, R. L. & Kelley, W. N. Gout and hyperuricemia. In Ruddy, S., Harris, E. D. Jr., & Sledge, C. B., eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia: W. B. Saunders, 2001: 1339–1376.Google Scholar

Reginato, A. J. & Reginato, A. M. Diseases associated with deposition of calcium pyrophosphate or hydroxyapatite. In Ruddy, S., Harris, E. D. Jr., & Sledge, C. B. eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia: W. B. Saunders, 2001: 1377–1390.Google Scholar

Ho, G. Jr.Gout and pseudogout in hospitalized patients. Arch. Intern. Med. 1993; 153: 2787–2790.CrossRefGoogle ScholarPubMed

Berger, R. G.Febrile presentation of calcium pyrophosphate dihydrate deposition disease. J. Rheumatol. 1988; 15: 642–643.Google ScholarPubMed

Mavrikakis, M. E.CPPD crystal deposition disease as a cause of unrecognized pyrexia. Clin. Exp. Rheumatol. 1994; 12: 419–422.Google Scholar

Roberts, W. N., Liang, M. H., Stern, S. H.Colchicine in acute gout: reassessment of risk and benefits. J. Am. Med. Assoc. 1987; 257: 1920–1922.CrossRefGoogle ScholarPubMed

Emmerson, B. T.The management of gout. N. Engl. J. Med. 1996; 334: 445–451.CrossRefGoogle ScholarPubMed

Axelrod, D. & Preston, S.Comparison of parenteral adrenocorticotrophic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum. 1988; 31: 803–805.CrossRefGoogle ScholarPubMed

Everdingen, A. A., Jacobs, J. W. G., Reesema, D. R. S.et al. Low dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. Ann. Intern. Med. 2002; 136: 1012.Google ScholarPubMed

Conn, D. L.Resolved: Low-dose prednisone is indicated as standard treatment in patients with rheumatoid arthritis. Arthritis Rheum. (Arthritis Care Res.) 2001; 45: 462–467.3.0.CO;2-V>CrossRefGoogle ScholarPubMed

Zonana-Nacach, A., Barr, S. G., Magder, L. S.et al. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000; 43: 1801–1808.3.0.CO;2-O>CrossRefGoogle ScholarPubMed

Gurley, J. P. & Bell, G. R.The surgical management of patients with rheumatoid cervical spine disease. Rheum. Dis. Clin. North Am. 1997; 23: 317–332.CrossRefGoogle ScholarPubMed

Conlon, P. W., Isdale, I. C. & Rose, B. S.Rheumatoid arthritis of the cervical spine. An analysis of 333 cases. Ann. Rheum. Dis. 1966; 25: 120–126.CrossRefGoogle ScholarPubMed

Eulderink, F. & Meijers, K. A. E.Pathology of the cervical spine in rheumatoid arthritis. A controlled study of 44 spines. J. Pathol. 1976; 120: 91–108.CrossRefGoogle ScholarPubMed

Pellicci, D. M., Ranawat, C. S., Tsairis, P.et al. A prospective study of the progression of rheumatoid arthritis of the cervical spine. J. Bone Joint Surg. Am. 1981; 63: 342–350.CrossRefGoogle ScholarPubMed

Rana, N. A.Natural history of atlantoaxial subluxation in rheumatoid arthritis. Spine 1989; 14: 1054–1056.CrossRefGoogle Scholar

Smith, P. H., Benn, R. & Sharp, J.Natural history of rheumatoid cervical subluxations. Ann. Rheum. Dis. 1972; 31: 431–439.CrossRefGoogle ScholarPubMed

Komusi, T., Munro, T. & Harth, M.Radiologic review: the rheumatoid cervical spine. Semin. Arthritis Rheum. 1985; 14: 187–195.CrossRefGoogle ScholarPubMed

Crosby, E. T.The adult cervical spine: implications for airway management. Can. J. Anaesth. 1990; 37: 77–93.CrossRefGoogle ScholarPubMed

Harris, E. D. Jr. Clinical features of rheumatoid arthritis. In Ruddy, S., Harris, E. D. Jr., & Sledge, C. B., eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia: W. B. Saunders, 2001: 967–1000.Google Scholar

Vasculitis. In Klippel, J. H. & Dieppe, P. A., eds. Rheumatology, 2nd edn. Volume 2. London: Mosby, 1998, Section 7: Chapters 17–31.Google Scholar